FDA approval for first generic glucagon emergency kit
The FDA has approved the first generic version of a glucagon emergency kit from Amphastar Pharmaceuticals, the Glucagon for Injection Emergency Kit 1mg. The generic glucagon for injection is a synthetic version of human glucagon. The company intends to launch the product within the next two months. The drug is also indicated as a diagnostic aid in the radiologic examination of the stomach, duodenum, small bowel and colon when diminished intestinal motility would be advantageous. There is a possibility of side effects as well associated with glucagon for injection which include nausea and vomiting, a temporary increase in heart rate, as well as redness and swelling of the injection site.